Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA.

Loktionov A, Hollstein M, Martel N, Galendo D, Cabral JR, Tomatis L, Yamasaki H.

Mol Carcinog. 1990;3(3):134-40.

PMID:
1973614
3.

Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation.

Loktionov A, Popovich I, Zabezhinski M, Martel N, Yamasaki H, Tomatis L.

Carcinogenesis. 1992 Jan;13(1):19-24.

PMID:
1733568
4.

Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.

Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Ledwith BJ, van Zwieten MJ, Bradley MO, Nichols WW.

Cancer Res. 1992 Jun 15;52(12):3347-52.

5.

[Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene].

Loktionov AS, Hollstein M, Martel N, Galendo D, Tomatis L, Yamasaki H.

Vopr Onkol. 1991;37(3):297-303. Russian.

PMID:
1903226
6.

Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.

Khan SG, Mohan RR, Katiyar SK, Wood GS, Bickers DR, Mukhtar H, Agarwal R.

Mol Carcinog. 1996 Feb;15(2):96-103.

PMID:
8599584
7.

Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.

Zhang Z, Diwan BA, Anderson LM, Logsdon D, Olivero OA, Haines DC, Rice JM, Yuspa SH, Poirier MC.

Mol Carcinog. 1998 Sep;23(1):45-51.

PMID:
9766437
8.

Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice.

Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Hammermeister CL, Joslyn DJ, Ledwith BJ, van Zwieten MJ, Bradley MO, et al.

Mol Carcinog. 1992;6(1):68-75.

PMID:
1503645
9.

Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.

Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H.

Mol Carcinog. 2000 Apr;27(4):298-307.

PMID:
10747294
10.

N-ras mutation in ultraviolet radiation-induced murine skin cancers.

Pierceall WE, Kripke ML, Ananthaswamy HN.

Cancer Res. 1992 Jul 15;52(14):3946-51.

11.
12.

Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.

Goodrow T, Reynolds S, Maronpot R, Anderson M.

Cancer Res. 1990 Aug 1;50(15):4818-23.

13.

Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.

Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS.

Carcinogenesis. 1998 Jun;19(6):1045-52.

14.
15.

Frequent Ha-ras mutations in murine skin and liver tumors induced by 7H-dibenzo[c,g]carbazole.

Mitchell KR, Warshawsky D.

Mol Carcinog. 1999 Jun;25(2):107-12.

PMID:
10365912
16.

Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.

Kumar R, Medina D, Sukumar S.

Oncogene. 1990 Aug;5(8):1271-7.

PMID:
2118247
17.

Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.

Bizub D, Wood AW, Skalka AM.

Proc Natl Acad Sci U S A. 1986 Aug;83(16):6048-52.

18.

ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse.

Herzog CR, Schut HA, Maronpot RR, You M.

Mol Carcinog. 1993;8(3):202-7.

PMID:
8216739
19.
Items per page

Supplemental Content

Write to the Help Desk